European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-24

European multiple system atrophy study group

Objetivo

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder, which frequently presents with the features of Parkinson's Disease, but in contrast to latter, causes early death and prolonged severe disability. The proposed concerted action will pave the way towards neuroprotective intervention trials in MSA by developing a trial protocol 'CAPIT-MSA) and by implementing a central MSA Registry (EMSA-R) for centralized data acquisition during a multicoated natural history study that will enable us to define rates of disease progression and to validate the CAPIT-MSA protocol. Furthermore, candidate neuroprotective agents will be screened in proof of concept studies using an established animal model of striatonigral degeneration. Pending ongoing preclinical safety and phase I studies of these agents by the industrial partners, one of the agents will be selected foray multicoated safety and tolerability phase II trial commencing at month 18.

Ámbito científico

Programa(s)

Tema(s)

Convocatoria de propuestas

Data not available

Régimen de financiación

CON - Coordination of research actions

Coordinador

UNIVERSITY HOSPITAL INNSBRUCK
Aportación de la UE
Sin datos
Dirección
Anichstrasse 35
6020 INNSBRUCK
Austria

Ver en el mapa
Coste total
Sin datos

Participantes (20)

Compartir esta página

Descargar

Última actualización: 12 Abril 2005

Mi folleto

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2000-00661/es

European Union, 2024